SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 85 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,260,000 | -0.9% | 500,000 | +42.9% | 2.39% | -1.2% |
| Q2 2023 | $7,325,500 | +6.7% | 350,000 | +7.7% | 2.42% | +19.2% |
| Q1 2023 | $6,864,000 | +79.8% | 325,000 | +116.7% | 2.03% | +24.5% |
| Q4 2022 | $3,818,000 | -20.6% | 150,000 | -25.0% | 1.63% | +20.8% |
| Q3 2022 | $4,806,000 | +11.0% | 200,000 | -11.1% | 1.35% | -40.2% |
| Q2 2022 | $4,329,000 | +10.7% | 225,000 | 0.0% | 2.26% | +165.6% |
| Q1 2022 | $3,911,000 | -40.4% | 225,000 | -25.0% | 0.85% | -63.9% |
| Q4 2021 | $6,567,000 | -40.2% | 300,000 | -47.8% | 2.35% | -26.8% |
| Q3 2021 | $10,988,000 | -26.9% | 575,000 | -34.3% | 3.21% | -22.2% |
| Q2 2021 | $15,024,000 | -42.8% | 875,000 | -25.5% | 4.13% | -33.1% |
| Q1 2021 | $26,273,000 | -12.5% | 1,175,000 | -13.0% | 6.18% | -7.7% |
| Q4 2020 | $30,024,000 | +378.6% | 1,350,000 | +217.6% | 6.69% | +269.0% |
| Q3 2020 | $6,273,000 | +128.8% | 425,000 | +129.7% | 1.81% | +150.8% |
| Q2 2020 | $2,742,000 | -0.0% | 185,000 | -26.0% | 0.72% | -0.7% |
| Q1 2020 | $2,743,000 | -1.8% | 250,000 | +25.0% | 0.73% | +25.3% |
| Q2 2017 | $2,794,000 | – | 200,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
| Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
| Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
| Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
| Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
| ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
| COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
| SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
| Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
| HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |